☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Adults
AbbVie-Skyrizi (risankizumab) Receives CHMP's Positive Opinion for the Treatment of Adults with Active Psoriatic Arthritis in the...
October 18, 2021
Sanofi's Sarclisa (isatuximab) Receives EC's Approval for adults with Relapsed and Refractory Multiple Myeloma
April 19, 2021
Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults & Pediatric patients with R/R cHL
March 18, 2021
Vir and GSK Provide Update on ACTIV-3 Trial of VIR-7831 in Hospitalized Adults with COVID-19
March 4, 2021
Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder
February 26, 2021
Amgen Reports sNDA Submission of Otezla (apremilast) to The US FDA's for Adults with Mild to Moderate Plaque Psoriasis
February 23, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.